Table 2. Univariate and multivariate Cox regression analysis for overall survival of gastric cancer patients.
Variables | Univariate |
Multivariate |
||||
---|---|---|---|---|---|---|
HR | 95% CI | P-value | HR | 95% CI | P-value | |
Gender | ||||||
Male vs female | 1.292 | 0.791–2.110 | 0.313 | |||
Age (years) | ||||||
≥60 vs <60 | 1.373 | 0.859–2.195 | 0.237 | |||
Tumor site | ||||||
Cardia+body vs antrum | 1.263 | 0.777–2.053 | 0.318 | |||
Lauren type | ||||||
Diffuse+mixture vs intestinal | 1.494 | 0.920–2.426 | 0.123 | |||
Differentiation | ||||||
Poorly vs well/moderately | 1.140 | 0.638–2.039 | 0.708 | |||
Vessel invasion | ||||||
Positive vs negative | 2.711 | 1.588–4.628 | <0.001 | 1.543 | 0.939–2.534 | 0.087 |
T stage | ||||||
T3–T4 vs T1–T2 | 3.516 | 2.104–5.877 | <0.001 | 4.863 | 1.192–19.847 | 0.027 |
Lymph node metastasis | ||||||
Positive vs negative | 4.038 | 2.516–6.481 | <0.001 | 3.425 | 1.108–10.589 | 0.033 |
Distant metastasis | ||||||
M1 vs M0 | 19.81 | 1.234–318.1 | 0.046 | 1.334 | 0.314–5.662 | 0.696 |
TNM stage | ||||||
III–IV vs I–II | 4.258 | 2.656–6.825 | <0.001 | 0.867 | 0.239–3.142 | 0.828 |
calpain-9 expression | ||||||
High vs low | 0.280 | 0.175–0.450 | <0.001 | 0.387 | 0.209–0.715 | 0.002 |
CI, Confidence interval; HR, Hazard ratio; P < 0.05 was considered to be statistically significant.